Literature DB >> 22361078

Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure.

Stavros E Mountantonakis1, Maria V Grau-Sepulveda, Deepak L Bhatt, Adrian F Hernandez, Eric D Peterson, Gregg C Fonarow.   

Abstract

BACKGROUND: It is unclear if the presence of atrial fibrillation (AF) on admission is associated with worse in-hospital outcomes in patients hospitalized with heart failure (HF). This study evaluated the clinical characteristics, management, length of stay, and mortality of HF patients with and without AF. METHODS AND
RESULTS: We studied 99 810 patients from 255 sites admitted with HF enrolled in Get With The Guidelines-Heart Failure between January 1, 2005, and December 31, 2010. Patients with AF on admission were compared with patients in sinus rhythm. A total of 31 355 (31.4%) HF patients presented with AF, of which 6701 (21.3%) were newly diagnosed. Patients in AF were older (77±12 versus 70±15, P<0.001) and were more likely to have history of stroke and valvular heart disease. AF patients had higher B-type natriuretic peptide levels and ejection fraction (42±17% versus 39±17%, P<0.001). AF patients were more likely to be hospitalized >4 days (48.8% versus 41.5%, P<0.001), discharged to a facility other than home (28.5% versus 19.7%, P<0.001), and had higher hospital mortality rate (4.0% versus 2.6%, P<0.001). AF, particularly newly diagnosed, was independently associated with adverse outcomes (adjusted odds ratios and 95% confidence intervals for mortality 1.17, 1.05-1.29, P=0.0029, and 1.29, 1.10-1.52, P=0.0023 for AF and newly diagnosed AF, respectively).
CONCLUSIONS: In patients hospitalized with HF, AF is present in one-third and is independently associated with adverse hospital outcomes and longer length of stay. Whether prompt restoration of sinus rhythm would improve outcomes in patients hospitalized with HF and new-onset or paroxysmal AF is unclear and requires further study.

Entities:  

Mesh:

Year:  2012        PMID: 22361078     DOI: 10.1161/CIRCHEARTFAILURE.111.965681

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  36 in total

1.  History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.

Authors:  Ravi B Patel; Muthiah Vaduganathan; Aruna Rikhi; Hrishikesh Chakraborty; Stephen J Greene; Adrian F Hernandez; G Michael Felker; Margaret M Redfield; Javed Butler; Sanjiv J Shah
Journal:  JACC Heart Fail       Date:  2018-11-05       Impact factor: 12.035

Review 2.  Atrial Fibrillation in Heart Failure-Diagnostic, Therapeutic, and Prognostic Relevance.

Authors:  Clara Stegmann; Gerhard Hindricks
Journal:  Curr Heart Fail Rep       Date:  2019-08

Review 3.  Invasive therapies for patients with concomitant heart failure and atrial fibrillation.

Authors:  Wei Wei; Michael Shehata; Xunzhang Wang; Fang Rao; Xianzhan Zhan; Huiming Guo; Xianhong Fang; Hongtao Liao; Jian Liu; Hai Deng; Yang Liu; Yumei Xue; Shulin Wu
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

Review 4.  Atrial Fibrillation in Patients with Ischemic and Non-Ischemic Left Ventricular Dysfunction.

Authors:  Robin Ducas; Vignendra Ariyarajah
Journal:  J Atr Fibrillation       Date:  2013-02-12

5.  Atrial fibrillation in heart failure: The sword of Damocles revisited.

Authors:  Muhammad A Khan; Fozia Ahmed; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2013-07-26

Review 6.  Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-09-09       Impact factor: 1.976

7.  Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.

Authors:  Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Robert Giugliano; Christopher B Granger; Kenneth W Mahaffey; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa-Filho; Marcia M Barbosa; Maria da Consolacao V Moreira; Renato A K Kalil; Marildes Freitas; Joao Carlos de Campos Guerra; Marcio Vinicius Lins Barros; Thiago da Rocha Rodrigues; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 8.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

Review 9.  Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.

Authors:  Nileshkumar J Patel; Aashay Patel; Kanishk Agnihotri; Dhaval Pau; Samir Patel; Badal Thakkar; Nikhil Nalluri; Deepak Asti; Ritesh Kanotra; Sabeeda Kadavath; Shilpkumar Arora; Nilay Patel; Achint Patel; Azfar Sheikh; Neil Patel; Apurva O Badheka; Abhishek Deshmukh; Hakan Paydak; Juan Viles-Gonzalez
Journal:  World J Cardiol       Date:  2015-07-26

10.  Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study).

Authors:  David D McManus; Jane S Saczynski; Darleen Lessard; Menhel Kinno; Rahul Pidikiti; Nada Esa; Josephine Harrington; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2013-05-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.